Adrenaline (epinephrine) – March 2026

Nasal spray device 1 mg in 1 actuation, Nasal spray device 2 mg in 1 actuation,

  • Brand names:
    • Neffy®
  • Pharmaceutical Company:
    • SEQIRUS (AUSTRALIA) PTY LTD
  • Condition/Indication: Acute allergic reaction with anaphylaxis
  • Meeting Date: March 2026
Public Summary Documents
Last updated
11 March 2026